A detailed history of Granite Group Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Granite Group Advisors, LLC holds 4,286 shares of AZN stock, worth $284,590. This represents 0.21% of its overall portfolio holdings.

Number of Shares
4,286
Previous 4,286 -0.0%
Holding current value
$284,590
Previous $334 Million 0.1%
% of portfolio
0.21%
Previous 0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$66.81 - $80.83 $51,710 - $62,562
774 Added 22.04%
4,286 $334 Million
Q4 2023

Apr 03, 2024

BUY
$61.89 - $69.28 $217,357 - $243,311
3,512 New
3,512 $238 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Granite Group Advisors, LLC Portfolio

Follow Granite Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Group Advisors, LLC with notifications on news.